Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Receivables (2020 - 2025)

NeuroPace has reported Receivables over the past 6 years, most recently at $14.7 million for Q4 2025.

  • Quarterly results put Receivables at $14.7 million for Q4 2025, up 13.95% from a year ago — trailing twelve months through Dec 2025 was $14.7 million (up 13.95% YoY), and the annual figure for FY2025 was $14.7 million, up 13.95%.
  • Receivables for Q4 2025 was $14.7 million at NeuroPace, up from $100000.0 in the prior quarter.
  • Over the last five years, Receivables for NPCE hit a ceiling of $14.7 million in Q4 2025 and a floor of $100000.0 in Q1 2025.
  • Median Receivables over the past 5 years was $9.1 million (2022), compared with a mean of $9.1 million.
  • Biggest five-year swings in Receivables: skyrocketed 64.58% in 2023 and later tumbled 99.14% in 2025.
  • NeuroPace's Receivables stood at $7.1 million in 2021, then grew by 5.51% to $7.5 million in 2022, then skyrocketed by 64.58% to $12.3 million in 2023, then grew by 4.76% to $12.9 million in 2024, then rose by 13.95% to $14.7 million in 2025.
  • The last three reported values for Receivables were $14.7 million (Q4 2025), $100000.0 (Q3 2025), and $13.6 million (Q2 2025) per Business Quant data.